Searched for
HUPERZINE A
- Shasun Pharmaceuticals in licensing pact with Swiss-based DebiopharmShasun Pharmaceuticals would be able to use the Debiopharm technology for manufacturing synthetic Huperzine-A and commercialise it.
- Load More
Alta Capital-backed Elevate, IIT Madras in pact for 1,800-bed student housing project
Tech entrepreneurs seeking the next AI frontier are pivoting from chatbots to 'world models'
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analysts
This NASA rover Perseverance just logged 26.2 miles on Mars. What it found could be even bigger
S&P upgrades Bharti Airtel to 'BBB+' on strong India, Africa growth and debt reduction prospects
Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service